Epidemiology of multiple sclerosis in south-western Sardinia

Background: Sardinia is a known high-risk area for multiple sclerosis (MS), but no data for south-western Sardinia (SWS) are available. SWS has a genetically homogeneous population, apart from St Peter Island, and represents a peculiar environment related to the industrial, mineralogical and military economy. Objective: To estimate prevalence and incidence and to evaluate temporal trends and geographical distribution of MS in SWS. Methods: MS prevalence was evaluated on 31 December 2007 and crude mean annual incidence rate was defined between 2003 and 2007. Temporal trend in MS incidence was assessed using the Armitage test. To identify MS clusters, Standard Morbidity Ratio (SMR) was calculated for each village and geographical distribution prevalence by means of a Bayesian hierarchical model. Results: Total crude prevalence rate was 210.4 (95% CI 186.3–234.5): 280.3 (95% CI 241.4–319.3) for females, 138 (95% CI 110.1–165.8) for males. The crude mean annual incidence rate was 9.7/100,000 (95% CI 3.4–13.2): 4.7/100,000 (95% CI 2.4–17.0) and 14.6/100,000 (95% CI 11.8–34.8) for males and females respectively. MS incidence has increased over the last 50 years. Cluster analysis showed an SMR of 0.2 (95% CI 0.05–0.68, p = 0.002) on the island of San Pietro, and 2.0 (95% CI 1.35–2.95, p = 0.001) in Domusnovas. Spatial distribution of MS was confirmed by Bayesian geographical analysis. Conclusions: Our data confirm Sardinia as a high-risk area for MS and support the relevance of genetic factors in MS, as evidenced in St Peter Island. However, we found an unexpectedly high MS prevalence in one village, in particular in males, suggesting an environmental influence on MS occurrence.

[1]  R. Alp,et al.  Prevalence of Multiple Sclerosis Door-to-Door Survey in Maltepe, Istanbul, Turkey , 2006, Neuroepidemiology.

[2]  C Montomoli,et al.  Spatial correlation in ecological analysis. , 1993, International journal of epidemiology.

[3]  L. Messinis,et al.  Prevalence and Incidence of Multiple Sclerosis in Western Greece: A 23-Year Survey , 2008, Neuroepidemiology.

[4]  L Bernardinelli,et al.  Bayesian estimates of disease maps: how important are priors? , 1995, Statistics in medicine.

[5]  Steve Selvin,et al.  Statistical Analysis of Epidemiologic Data , 1991 .

[6]  Andrew Thomas,et al.  WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..

[7]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[8]  N. Vella,et al.  Multiple sclerosis in Malta in 1999: an update , 2002, Journal of neurology, neurosurgery, and psychiatry.

[9]  T. Riise,et al.  Increasing Incidence of Multiple Sclerosis in the Province of Sassari, Northern Sardinia , 2005, Neuroepidemiology.

[10]  L. Bernardinelli,et al.  An Ecologic Study of Geographical Variation in Multiple Sclerosis Risk in Central Sardinia, Italy , 2002, Neuroepidemiology.

[11]  A. Dempster,et al.  A Bayesian approach to the multiplicity problem for significance testing with binomial data. , 1987, Biometrics.

[12]  E. Granieri,et al.  The increasing incidence and prevalence of MS in a Sardinian province , 2000, Neurology.

[13]  M. Hernán,et al.  Temporal trends in the incidence of multiple sclerosis , 2008, Neurology.

[14]  P. Moral,et al.  Genetics, geography, and culture: the population of S. Pietro Island (Sardinia, Italy). , 1996, American journal of physical anthropology.

[15]  J. Bach,et al.  The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update , 2010, Clinical and experimental immunology.

[16]  P. Donnan,et al.  Multiple sclerosis distribution in northern Sardinia: spatial cluster analysis of prevalence. , 2002, Neurology.

[17]  L. Grimaldi,et al.  High Prevalence and Fast Rising Incidence of Multiple Sclerosis in Caltanissetta, Sicily, Southern Italy , 2006, Neuroepidemiology.

[18]  G. Rosati,et al.  Clinical Neurology and Neurosurgery the Worldwide Prevalence of Multiple Sclerosis , 2022 .

[19]  C. Poser.  The dissemination of multiple sclerosis: A Viking saga? A historical essay , 1994, Annals of neurology.

[20]  P. Elliott,et al.  Spatial Epidemiology: Current Approaches and Future Challenges , 2004, Environmental health perspectives.

[21]  F. Cucca,et al.  The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. , 2000, Tissue antigens.

[22]  L. Grimaldi,et al.  High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy , 2001, Neurology.

[23]  L Bernardinelli,et al.  Empirical Bayes versus fully Bayesian analysis of geographical variation in disease risk. , 1992, Statistics in medicine.

[24]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.